Amicus Therapeutics, Inc. Share Price
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05/05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 29/04 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
| Market Cap | 454.99Cr 399.8Cr 373.18Cr 342.48Cr 641.1Cr 44TCr 656.91Cr 4.43TCr 1.73TCr 22TCr 1.71TCr 1.67TCr 75TCr | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 469.87Cr 412.87Cr 385.39Cr 353.69Cr 662.07Cr 45TCr 678.4Cr 4.57TCr 1.79TCr 22TCr 1.76TCr 1.73TCr 77TCr | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics, Inc.
| 1 day | +0.21% | ||
| 6 months | +1.54% | ||
| Current year | +1.76% |
| Current year | 14.2 |  | 14.5 |
| 1 year | 5.92 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 27/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/01/26 | Fiscal year | Chief Executive Officer | 2,25,000 | 0.0727% | ||
| 02/01/26 | Tax | General Counsel | 43,109 | 0.0139% | ||
| 02/01/26 | Tax | Executive/Senior Manager | 30,007 | 0.0097% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +136.38% | +6.78% | 454.99Cr | |
| -0.68% | +5.86% | -0.03% | +13.62% | 4.89TCr | |
| -4.78% | +14.36% | +23.78% | +5.96% | 4.07TCr | |
| +3.42% | -1.34% | +403.12% | +609.45% | 3.85TCr | |
| -3.12% | -2.56% | +6.16% | +48.64% | 3.64TCr | |
| +1.47% | +5.82% | +5.76% | +43.52% | 2.84TCr | |
| -1.69% | -2.63% | - | - | 1.66TCr | |
| -2.25% | -5.54% | +30.71% | +126.03% | 1.63TCr | |
| -8.17% | -3.76% | -9.69% | -34.80% | 1.36TCr | |
| -0.41% | +3.51% | +3.57% | +9.36% | 1.36TCr | |
| Average | -1.39% | +5.10% | +66.64% | +92.06% | 2.58TCr | |
| Weighted average by Cap. | -1.09% | +6.56% | +74.25% | +120.70% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 53Cr 46Cr 43Cr 40Cr 74Cr 5.06TCr 76Cr 513.82Cr 200.94Cr 2.5TCr 198.35Cr 194.04Cr 8.66TCr | 63Cr 56Cr 52Cr 48Cr 89Cr 6.07TCr 92Cr 616.83Cr 241.23Cr 3.01TCr 238.11Cr 232.95Cr 10TCr |
| Net income | -5.61Cr -4.93Cr -4.6Cr -4.22Cr -7.91Cr -537.4Cr -8.1Cr -55Cr -21Cr -265.93Cr -21Cr -21Cr -919.31Cr | -2.71Cr -2.38Cr -2.22Cr -2.04Cr -3.82Cr -259.67Cr -3.91Cr -26Cr -10Cr -128.5Cr -10Cr -9.96Cr -444.21Cr |
| Net Debt | 19Cr 17Cr 16Cr 15Cr 27Cr 1.86TCr 28Cr 188.39Cr 74Cr 918.08Cr 73Cr 71Cr 3.17TCr | 15Cr 13Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 144.75Cr 57Cr 705.41Cr 56Cr 55Cr 2.44TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- FOLD Stock
Select your edition
All financial news and data tailored to specific country editions
